Aggrenox Articles

Boehringer's 2008 net sales jump 6.4%

24 April 2009

Nippon Boeh Ing again records fastest growth in Japan's ethical drug market

28 April 2008

Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M

14 April 2008

Barr challenges Boeh Ing's Aggrenox patent

23 July 2007

R&D continues to be key for Germany's Boehringer Ingelheim

2 April 2007

Record growth for Boeh Ing Japan

1 May 2006

Boeh Ingelheim launches largest-ever stroke prevention trial with dipyridamole

2 June 2003

Boeh Ingelheim starts two mega-trials

24 February 2003

BI's Aggrenox OKed in USA

25 November 1999

Aggrenox recommended

29 April 1999

BI granted a priority review for Aggrenox

4 March 1999

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end